Indogulf Cropsci (IGCL)

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• Valuation is reasonable: P/E of 11.63 and P/B of 1.10 near book value.
• Promoter holding of 69.05% aligns promoter interests with minority shareholders.
• Debt/Equity of 0.47 is moderate, and Piotroski F-Score of 7/9 indicates decent financial health.
• Sales growth of 10.38% and profit growth of 8.36% show modest positive momentum.
• Price near ₹62.12 is far below the 52-week high of ₹118.99, offering a potential margin of safety if earnings stabilize.

Concerns

• Latest quarter net profit of just ₹4 Cr on sales of ₹109 Cr highlights thin margins and earnings fragility.
• No dividend means investors get no income while waiting for growth or re-rating.
• Agrochemicals are commoditized with limited pricing power and low customer loyalty, reducing moat quality.
• Price has fallen sharply from ₹118.99 to ₹62.12, suggesting possible cyclical pressure or structural de-rating.

AI Analysis

Indogulf CropSci doesn't immediately strike me as a wonderful compounder. It sells pesticides and agrochemicals, a business where farmers care about price and efficacy; switching costs are low and brands don't create deep loyalty. That caps the moat. At ₹62.12, the market cap is ₹417 Cr, the P/E is 11.63, P/B is 1.10, and book value is ₹56.42, so you're not paying a rich price. But a low price isn't the same as undervaluation. ROCE of 13.15% is decent, yet the latest quarter tells another story: sales of ₹109 Cr but net profit of only ₹4 Cr — under 4% net margin. For the full year, earnings appear around ₹36 Cr if the multiple is correct, but the quarterly figure shows volatility. Debt/equity of 0.47 is manageable, and a Piotroski F-Score of 7/9 suggests the balance sheet isn't deteriorating. Promoter holding of 69.05% is a positive; owners have skin in the game. Still, zero dividend means shareholder returns depend entirely on growth and multiple. Sales growth of 10.38% and profit growth of 8.36% are moderate, and with a PEG of 1.24, the stock isn't statistically cheap for its growth. The 52-week range of ₹49.46 to ₹118.99 shows this is a cyclical, not a stable wealth compounder. I'd want a bigger margin of safety in a commodity agrochemical business, especially when latest quarterly profit is thin. It's not a terrible business; it's an average business at a fair price. For an Indian retail investor, this may deserve a small watchlist position, not a conviction buy. I prefer durable advantages and predictable earnings; Indogulf has neither, and the recent drawdown reflects that.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer